About: Laboratory Processing of Specimens

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Laboratory Processing of Specimens Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Laboratory Processing of Specimens
Creator	Herrera, Vicki Hinrichs, Steven Alter, Roxanne Alter, · Iwen, Peter Herrera, V Hinrichs, S Iwen, P Sambol, Anthony Sambol, · Stiles, Karen Stiles, ·
Source	PMC
abstract	Although not always the first topic discussed when preparing for a bioemergency, the availability of a competent clinical laboratory is vital for the optimal care of a patient with a risk group 4 (RG-4) high-consequence pathogen. The recent development of highly specialized facilities in the United States to assess and treat patients with highly hazardous communicable diseases has led to the design of dedicated laboratories or the redesign of laboratory space to safely process and test specimens that might contain one of these pathogens. For frontline and other acute care facilities to be prepared, safety practices need to be assessed and reviewed as necessary as pertaining to all laboratory activities, to include the pre-analytical (specimen collection and processing), analytical (specimen testing), and post-analytical (specimen disposal/waste management and reporting) processes. Laboratorians and administrative personnel need to consider the risks in handling specimens containing these pathogens and subsequently develop or revise processes to mitigate risks. In addition, issues such as scalability to handle large volume testing, the availability of trained staff, and long-term sustainability to meet the requirements of regulatory agencies need to be adopted within a fiscally responsible budget setting. This chapter provides generalized information on how clinical laboratories, from those supporting small frontline medical facilities to highly specialized laboratories supporting acute care treatment centers, can safely manage specimens from a patient known or potentially infected with a high-consequence pathogen.
has issue date	2018-07-07(xsd:dateTime)
bibo:doi	10.1007/978-3-319-77032-1_6
has license	no-cc
sha1sum (hex)	e1430612cd37a95fd518fc21e38ae0ff09fd57aa
schema:url	https://doi.org/10.1007/978-3-319-77032-1_6
resource representing a document's title	Laboratory Processing of Specimens
has PubMed Central identifier	PMC7122885
schema:publication	Bioemergency Planning
resource representing a document's body	covid:e1430612cd37a95fd518fc21e38ae0ff09fd57aa#body_text
is schema:about of	named entity 'SPECIMENS' named entity 'LABORATORY' named entity 'PROCESSING' named entity 'biohazard bag' named entity 'pathogens' named entity 'highly hazardous' named entity 'healthcare facilities' named entity 'CDC' named entity 'pathogen' named entity 'biohazard bag' named entity 'infection control' named entity 'CDC' named entity 'laboratory testing' named entity 'medical facilities' named entity 'patient isolation' named entity 'pathogens' named entity 'select agent' named entity 'medical care' named entity 'hospital laboratory' named entity 'pathogen' named entity 'pathogens' named entity 'therapeutic interventions' named entity 'pathogen' named entity 'CLIA' named entity 'personal protective equipment (PPE' named entity 'risk assessment' named entity 'Clinical Laboratory Improvement Amendments' named entity 'disinfectant' named entity 'biohazard' named entity 'centrifugation' named entity 'disinfectant' named entity 'PPE' named entity 'nucleic acid' named entity 'infection' named entity 'Ebola epidemic' named entity 'risk assessment' named entity 'disinfectant' named entity 'epidemic' named entity 'electrolyte' named entity 'CDC' named entity 'influenza' named entity 'PPE' named entity 'aerosols' named entity 'quality management' named entity 'syringe' named entity 'disinfection' named entity 'Ebola' named entity 'disinfectant' named entity 'CDC' named entity 'critical access hospital' named entity 'patient specimens' named entity 'public health' named entity 'coagulation' named entity 'serological assay' named entity 'personal protective equipment (PPE' named entity 'disinfectant' named entity 'biohazard bag' named entity 'pathogens' named entity 'epidemic' named entity 'packaging and labeling' named entity 'risk assessment' named entity 'CDC' named entity 'waste container' named entity 'vacutainer' named entity 'biohazard bag' named entity 'select agent' named entity 'quality control' named entity 'decontamination' named entity 'malaria' named entity 'risk assessment' named entity 'public health' named entity 'LIS'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software